• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
HE Shuying, XIONG Rui, LIU Kun, XU Yungen. Molecular mechanisms of combretastatin A-4 amino sugar derivative CPU-XT-008 on inhibiting proliferation of vascular endothelial cells[J]. Journal of China Pharmaceutical University, 2015, 46(5): 594-599. DOI: 10.11665/j.issn.1000-5048.20150513
Citation: HE Shuying, XIONG Rui, LIU Kun, XU Yungen. Molecular mechanisms of combretastatin A-4 amino sugar derivative CPU-XT-008 on inhibiting proliferation of vascular endothelial cells[J]. Journal of China Pharmaceutical University, 2015, 46(5): 594-599. DOI: 10.11665/j.issn.1000-5048.20150513

Molecular mechanisms of combretastatin A-4 amino sugar derivative CPU-XT-008 on inhibiting proliferation of vascular endothelial cells

More Information
  • Taking human umbilical vein endothelial cells(HUVEC)as experimental model which can simulate tumor-derived vascular endothelial cells, the effects of CPU-XT-008, an amino sugar derivative of combretastatin A-4(CA-4), on HUVEC proliferation, cell cycle distribution, tubulin polymerization and the key regulatory protein of cell cycle were studied. The effect of CPU-XT-008 on the proliferation of HUVEC was determined by MTT assay. The cell cycle distribution caused by CPU-XT-008 was detected by flow cytometry. Immunofluorescence was used to detect apoptosis and tubulin polymerization. The expressions of Cyclin B1, Cdc2 and β-tubulin were detected by Western blotting. Results demonstrated that CPU-XT-008 could target tubulin and inhibit the polymerization of β-tubulin, and it could lead to G2/M cell cycle arrest in HUVEC by up-regulating Cyclin B1 expression and down-regulating Cdc2 and p-Cdc2 expression, which resulted in inhibiting the proliferation of HUVEC and inducing its apoptosis.
  • [1]
    Kretzschmann VK, Furst R. Plant-derived vascular disrupting agents:compounds,actions,and clinical trials[J].Phytochem Rev,2014,13(1):191-206.
    [2]
    Schwartz EL.Antivascular actions of microtubule-binding drugs[J].Clin Cancer Res,2009,15(8):2594-2601.
    [3]
    Wang XF,Wang SB,Ohkoshi E,et al.N-Aryl-6-methoxy-1,2,3,4-tetrahydroquinolines:a novel class of antitumor agents targeting the colchicine site on tubulin[J].Eur J Med Chem,2013,9(67):196-207.
    [4]
    Magalhães HI,Wilke DV,Bezerra DP,et al.(4-Methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone inhibits tubulin polymerization,induces G2/M arrest,and triggers apoptosis in human leukemia HL-60 cells[J].Toxicol Appl Pharmacol,2013,272(1):117-126.
    [5]
    Tripathi A,Fornabaio M,Kellogg GE,et al.Docking and hydropathic scoring of polysubstituted pyrrole compounds with antitubulin activity[J].Bioorg Med Chem,2008,16(5):2235-2242.
    [6]
    He SY,Sun J,Liu K,et al.Effect of combretastatin A-4 derivative CPU-XT-006 on proliferation,apoptosis and expression of VEGF and bFGF of HUVEC in vitro[J].J China Pharm Univ(中国药科大学学报),2013,44(5):451-454.
    [7]
    Kanthou C,Greco O,Stratford A,et al.The tubulin-binding agent combretastatin A-4-phosphate arrests endothelial cells in mitosis and induces mitotic cell death[J].Am J Pathol,2004,165(4):1401-1411.
  • Related Articles

    [1]MU Yao, ZHAO Huimin, LIU Haochen, LIU Xiaoquan. Advances in drug development for Alzheimer’s disease[J]. Journal of China Pharmaceutical University, 2024, 55(6): 816-825. DOI: 10.11665/j.issn.1000-5048.2024010202
    [2]XING Xuyang, WANG Xiaochun, HE Wei. Advances in research on tumor immunotherapy and its drug development[J]. Journal of China Pharmaceutical University, 2021, 52(1): 10-19. DOI: 10.11665/j.issn.1000-5048.20210102
    [3]MEI Jiahao, HONG Ze, WANG Chen. Advances of drugs in targeting cGAS-STING signaling pathway[J]. Journal of China Pharmaceutical University, 2020, 51(3): 249-259. DOI: 10.11665/j.issn.1000-5048.20200301
    [4]CHEN Xing, KANG Yang, WU Jun. Advances in biodegradable functional polymers based protein drug delivery system[J]. Journal of China Pharmaceutical University, 2017, 48(2): 142-149. DOI: 10.11665/j.issn.1000-5048.20170203
    [5]SU Zhigui, MO Ran, ZHANG Can. Advances of nano-drug delivery systems overcoming the physiological and pathological barriers of tumor[J]. Journal of China Pharmaceutical University, 2015, 46(1): 28-39. DOI: 10.11665/j.issn.1000-5048.20150103
    [6]YIN Lei, WANG Ying, CHEN Song, GAO Xiangdong. Advances of glucagon-like peptide-1 receptor agonists in the treatment of nervous system diseases[J]. Journal of China Pharmaceutical University, 2014, 45(4): 383-391. DOI: 10.11665/j.issn.1000-5048.20140401
    [7]WANG Yazhe, ZHOU Jianping, DING Yang, WANG Wei. Advances in research of biomimetic drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(3): 267-273. DOI: 10.11665/j.issn.1000-5048.20140303
    [8]WANG Juan, LIAO Hong. Advances in drug research and development through directed differentiation of stem cells[J]. Journal of China Pharmaceutical University, 2011, 42(3): 193-197.
    [9]XU Si-sheng, ZHANG Hui-bin, ZHOU Jin-pei, HUANG Jian-jun. Advances of new antidiabetic drugs[J]. Journal of China Pharmaceutical University, 2011, 42(2): 97-106.
    [10]Advances and Prospects of Drug Discovery and Development Zhang Yihua, Peng Sixun, Hua Weiyi[J]. Journal of China Pharmaceutical University, 1999, (2): 75-80.
  • Cited by

    Periodical cited type(6)

    1. 金伟斌,陈礼峰,唐倩倩,顾晓风. 顶空气相色谱法测定生脉注射液中甲醛和乙醛的含量. 中国合理用药探索. 2022(06): 115-120 .
    2. 李浩宇,唐宝强,何东升,涂家生. 气相色谱法测定药用辅料聚西托醇1000中的残留杂质. 中国药科大学学报. 2022(03): 293-299 . 本站查看
    3. 王贺,钱利武,阚红卫. 药用辅料监管法规、质量标准现状分析及应对措施. 中南药学. 2022(08): 1937-1941 .
    4. 庞丽然,贺丞,杜力,刘国芳. 重组蛋白中吐温80含量硫氰酸铵钴显色检测法的改进及验证. 中国生物制品学杂志. 2021(09): 1111-1113+1119 .
    5. 郑永强,付俊伟,朱慧敏,陶晓军. 一种用于实现脑靶向的负载长春新碱抗肿瘤纳米药物制剂的制备及表征. 肿瘤药学. 2021(05): 547-553 .
    6. 黄婧,吴宏伟. 依诺沙星滴眼液辅料及药包材相容性研究. 中国现代应用药学. 2021(22): 2802-2806 .

    Other cited types(2)

Catalog

    Article views (1078) PDF downloads (1568) Cited by(8)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return